Your cart is currently empty!
SANEXAS RST NeoGEN Neuropathy Pain Treatment System The Synaptic NeoGEN System is an advanced electrical cell signaling technology (EST) device designed for the treatment of neuropathy and chronic pain. Utilizing cutting-edge bio-electrical stimulation, the NeoGEN system promotes natural nerve cell communication and helps restore normal nerve function, offering patients a non-invasive, drug-free alternative to pain management.…
The Synaptic NeoGEN System is an advanced electrical cell signaling technology (EST) device designed for the treatment of neuropathy and chronic pain. Utilizing cutting-edge bio-electrical stimulation, the NeoGEN system promotes natural nerve cell communication and helps restore normal nerve function, offering patients a non-invasive, drug-free alternative to pain management.
Developed by Rebuilder Services Technologies (RST-SANEXAS), this system delivers multiple therapeutic frequencies to stimulate deep cellular repair and improve microcirculation — addressing the root cause of neuropathic pain rather than masking symptoms. The result is a safe, comfortable, and highly effective therapy for patients suffering from diabetic neuropathy, chronic pain, and nerve disorders.
⚡ Electrical Cell Signaling Therapy (EST) – Uses patented waveforms to restore nerve cell communication and function.
Multi-Frequency Stimulation – Targets deep and superficial tissues for comprehensive pain relief.
Non-Invasive & Drug-Free – Provides safe therapy without medications, injections, or surgery.
Patient-Friendly Design – Delivers gentle electrical pulses for comfortable, relaxing treatments.
Clinically Proven Results – Shown to reduce pain, tingling, and numbness associated with peripheral neuropathy.
Versatile Clinical Use – Ideal for pain management, physical therapy, and neurology practices.
Peripheral neuropathy (diabetic, idiopathic, chemotherapy-induced)
Chronic pain and nerve damage
Circulatory and neuromuscular disorders
Painful sensory neuropathy
Post-surgical and injury-related nerve pain
Technology: Electrical Cell Signaling (EST)
Frequency range: Variable, multi-waveform output
Output channels: Dual or multi-site therapy capability
Interface: Digital touchscreen with pre-set treatment protocols
Safety: FDA-cleared, non-invasive medical device
The NeoGEN Electrical Cell Signaling System represents the future of neuropathy and chronic pain therapy. By treating the underlying cause of nerve dysfunction through advanced bio-electrical stimulation, it empowers clinicians to deliver long-lasting pain relief and functional improvement — safely and effectively.